Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5287301
Max Phase: Preclinical
Molecular Formula: C36H51NO2
Molecular Weight: 529.81
Associated Items:
ID: ALA5287301
Max Phase: Preclinical
Molecular Formula: C36H51NO2
Molecular Weight: 529.81
Associated Items:
Canonical SMILES: C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(c6cccc(N)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
Standard InChI: InChI=1S/C36H51NO2/c1-22(2)25-13-18-36(31(38)39)20-19-34(6)27(30(25)36)11-12-29-33(5)16-14-26(23-9-8-10-24(37)21-23)32(3,4)28(33)15-17-35(29,34)7/h8-10,14,21,25,27-30H,1,11-13,15-20,37H2,2-7H3,(H,38,39)/t25-,27+,28-,29+,30+,33-,34+,35+,36-/m0/s1
Standard InChI Key: GDVTVSWGHSIYAF-PDVPNEPJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 529.81 | Molecular Weight (Monoisotopic): 529.3920 | AlogP: 9.00 | #Rotatable Bonds: 3 |
Polar Surface Area: 63.32 | Molecular Species: ACID | HBA: 2 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.88 | CX Basic pKa: 4.12 | CX LogP: 7.70 | CX LogD: 5.62 |
Aromatic Rings: 1 | Heavy Atoms: 39 | QED Weighted: 0.30 | Np Likeness Score: 2.39 |
1. Borková L, Frydrych I, Vránová B, Jakubcová N, Lišková B, Gurská S, Džubák P, Pavliš P, Hajdúch M, Urban M.. (2022) Lupane derivatives containing various aryl substituents in the position 3 have selective cytostatic effect in leukemic cancer cells including resistant phenotypes., 244 [PMID:36283179] [10.1016/j.ejmech.2022.114850] |
Source(1):